RaymondUOsarogiagbonMD

Physician

Overview of Dr. Osarogiagbon

Dr. Raymond Osarogiagbon is an oncologist in Memphis, TN and is affiliated with multiple hospitals in the area, including Baptist Memorial Hospital - Memphis, Baptist Memorial Hospital-Desoto, Baptist Memorial Hospital-Golden Triangle, Baptist Memorial Hospital for Women, Baptist Memorial Hospital-Tipton, Methodist Le Bonheur Germantown Hospital, Saint Francis Hospital, Saint Francis Hospital-Bartlett, and Methodist Healthcare Memphis Hospitals. He received his medical degree from University of Ibadan and has been in practice 29 years. Dr. Osarogiagbon accepts several types of health insurance, listed below. He is one of 56 doctors at Baptist Memorial Hospital - Memphis and one of 31 doctors at Methodist Le Bonheur Germantown Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.

Office
80 Humphreys Center
Suite 330
Memphis, TN 38120
Book by Phone+1(901) 676-8261

Fax+1 662-349-8551
Is this information wrong?

Education & Training

University of MinnesotaFellowship, Hematology and Medical Oncology, 1995 - 1998
Texas Tech University (Amarillo)Residency, Internal Medicine, 1992 - 1995
University of IbadanClass of 1988

Certifications & Licensure

TN State Medical License 2004 - 2025
MS State Medical License 2005 - 2024
MN State Medical License 1995 - 2014
TX State Medical License 2000 - 2014

Awards, Honors, & Recognition

Memphis Magazine: Top Doctors Castle Connolly, 2008-2014

Clinical Trials

Building a Multidisciplinary Bridge Across the Quality Chasm in Thoracic Oncology Start of enrollment: 2014 Oct 09
Completed
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
Completed
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Disparities in electronic health record portal access and use among patients with cancer.
Joan M Griffin, Barbara L Kroner, Sandra L Wong, Liliana Preiss, Ashley Wilder Smith, Andrea L Cheville, Sandra A Mitchell, Nicola Lancki, Michael J Hassett, Deborah S...> ;Journal of the National Cancer Institute. 2024 Mar 7
Effects of a change in recall period on reporting severe symptoms: an analysis of a pragmatic multisite trial.
Paudel, R., Uno, H., Cronin, C., Wong, S., Hazard Jenkins, H., Bian, J., Jensen, R., Mitchell, S., Enzinger, A., Dizon, D., Osarogiagbon, R., Schrag, D., Hassett, M.> ;Journal of the National Cancer Institute. 2024 Mar 5
Program-Based Lung Cancer Care: A Prospective Observational Tumor Registry Linkage Study.
Liao, W., Ray, M., Fehnel, C., Goss, J., Shepherd, C., Patel, A., Qureshi, T., Caro, F., Roma, J., Derrick, A., Matthews, A., Faris, N., Smeltzer, M., Osarogiagbon, R.> ;JTO Clinical and Research Reports. 2024 Feb 1
Strategies for Implementing an Electronic Patient-Reported Outcomes-Based Symptom Management Program Across Six Cancer Centers.
Hassett, M., Dias, S., Cronin, C., Schrag, D., McCleary, N., Simpson, J., Poirier-Shelton, T., Bian, J., Reich, J., Dizon, D., Begnoche, M., Jenkins, H., Tasker, L., W...> ;Research Square. 2024 Jan 24
1 citations
The Longitudinal Implementation Strategy Tracking System (LISTS): feasibility, usability, and pilot testing of a novel method.
Justin D Smith, Wynne E Norton, Sandra A Mitchell, Christine Cronin, Michael J Hassett, Jennifer L Ridgeway, Sofia F Garcia, Raymond U Osarogiagbon, Don S Dizon, Jessi...> ;Implementation Science Communications. 2023 Nov 28
Assessing Patient Readiness for an Electronic Patient-Reported Outcome-Based Symptom Management Intervention in a Multisite Study.
Roshan Paudel, Angela C Tramontano, Christine Cronin, Sandra L Wong, Don S Dizon, Hannah H Jenkins, Jessica Bian, Raymond U Osarogiagbon, Deborah Schrag, Michael J Has...> ;JCO Oncology Practice. 2024 Jan 1
Incidentally Detected Lung Cancer in Persons Too Young or Too Old for Lung Cancer Screening in a Mississippi Delta Cohort.
Wei Liao, Carrie Fehnel, Jordan Goss, Catherine J Shepherd, Talat Qureshi, Anberitha T Matthews, Meredith A Ray, Nicholas R Faris, Paul F Pinsky, Matthew P Smeltzer, R...> ;Journal of Thoracic Oncology. 2024 Apr 1
3 citations
Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials.
Ashley Wilder Smith, Lisa DiMartino, Sofia F Garcia, Sandra A Mitchell, Kathryn J Ruddy, Justin D Smith, Sandra L Wong, September Cahue, David Cella, Roxanne E Jensen,...> ;JNCI Cancer Spectrum. 2023 Oct 31
9 citations
The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the N Descriptors in the Forthcoming Ninth Ed...
James Huang, Raymond U Osarogiagbon, Dorothy J Giroux, Katherine K Nishimura, Andrea Bille, Giuseppe Cardillo, Frank Detterbeck, Kemp Kernstine, Hong Kwan Kim, Yolande...> ;Journal of Thoracic Oncology. 2023 Oct 20
Meta-Analysis of Rates and Risk Factors for Local Recurrence in Surgically Resected Patients With NSCLC and Differences Between Asian and Non-Asian Populations.
John M Varlotto, Cristina Bosetti, Dwight Bronson, Claudia Santucci, Maria Vitttoria Chiaruttini, Marco Scardapane, Minesh Mehta, David Harpole, Raymond Osarogiagbon, ...> ;JTO Clinical and Research Reports. 2023 Oct 1
Two Interventions on Pathologic Nodal Staging in a Population-Based Lung Cancer Resection Cohort.
Raymond U Osarogiagbon, Meredith A Ray, Carrie Fehnel, Olawale Akinbobola, Andrea Saulsberry, Kourtney Dortch, Nicholas R Faris, Anberitha T Matthews, Matthew P Smeltz...> ;The Annals of Thoracic Surgery. 2024 Mar 1
In Response: Taichiro Goto "Kit Use May Not Be Key To Improved Prognosis"; Response to "Akinbobola O, Ray MA, Fehnel C, et al. Institution-Level Evolution of Lung Canc...
Olawale Akinbobola, Meredith A Ray, Matthew P Smeltzer, Raymond U Osarogiagbon> ;Journal of Thoracic Oncology. 2023 Aug 1
2 citations
Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung ...
Stephen Lam, Chunxue Bai, David R Baldwin, Yan Chen, Casey Connolly, Harry de Koning, Marjolein A Heuvelmans, Ping Hu, Ella A Kazerooni, Harriet L Lancaster, Georg Lan...> ;Journal of Thoracic Oncology. 2024 Jan 1
Lung Cancer Patients' and Caregivers' Satisfaction With Multidisciplinary Versus Serial Care in a Community Healthcare Setting: A Prospective Comparative-Effectiveness...
Huibo Shao, Nicholas R Faris, Kenneth D Ward, Weiyu Chen, Laura McHugh, Matthew Smeltzer, Meredith A Ray, Raymond U Osarogiagbon> ;Clinical Lung Cancer. 2023 Nov 1
1 citations
Surgeon Quality and Patient Survival After Resection for Non-Small-Cell Lung Cancer.
Meredith A Ray, Olawale Akinbobola, Carrie Fehnel, Andrea Saulsberry, Kourtney Dortch, Bradley Wolf, Ganpat Valaulikar, Hetal D Patel, Thomas Ng, Todd Robbins, Matthew...> ;Journal of Clinical Oncology. 2023 Jul 10
In Response: Letter to the Editor: Re "Smeltzer MP, Liao W, Faris NR, et al. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for ...
Matthew P Smeltzer, Wei Liao, Raymond U Osarogiagbon> ;Journal of Thoracic Oncology. 2023 Jun 1
Diagnostic follow-up of indeterminate pulmonary nodules in the Medicare population.
Paul F Pinsky, Raymond Osarogiagbon> ;Cancer. 2023 Sep 15
2 citations
Institution-Level Evolution of Lung Cancer Resection Quality With Implementation of a Lymph Node Specimen Collection Kit.
Olawale Akinbobola, Meredith A Ray, Carrie Fehnel, Andrea Saulsberry, Kourtney Dortch, Matthew Smeltzer, Nicholas R Faris, Raymond U Osarogiagbon> ;Journal of Thoracic Oncology. 2023 Jul 1
5 citations
Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide.
Adam H Fox, Mizuki Nishino, Raymond U Osarogiagbon, M Patricia Rivera, Lauren S Rosenthal, Robert A Smith, Farhood Farjah, Lynette M Sholl, Gerard A Silvestri, Bruce E...> ;CA. 2023 Mar 1
3 citations
Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
Raymond U Osarogiagbon, Wei Liao, Nicholas R Faris, Carrie Fehnel, Jordan Goss, Catherine J Shepherd, Talat Qureshi, Anberitha T Matthews, Matthew P Smeltzer, Paul F P...> ;JAMA Network Open. 2023 Feb 1
4 citations
Expanding the Reach and Grasp of Lung Cancer Screening.
Raymond U Osarogiagbon, Pan-Chyr Yang, Lecia V Sequist> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 Jan 1
12 citations
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Overview of Challenges and Opportunities in Revising the Nodal Classification o...
Raymond Uyiosa Osarogiagbon, Paul Van Schil, Dorothy J Giroux, Eric Lim, Paul Martin Putora, Yolande Lievens, Giuseppe Cardillo, Hong Kwan Kim, Gaetano Rocco, Andrea B...> ;Journal of Thoracic Oncology. 2023 Apr 1
6 citations
Pulmonary Nodules, Lung Cancer Screening, and Lung Cancer in the Medicare Population.
Paul Pinsky, Eric Miller, Nick Faris, Raymond Osarogiagbon> ;Chest. 2023 May 1
Is it time to revise the International Association for the Study of Lung Cancer definitions of completeness of lung cancer resection?
Ramón Rami-Porta, John G Edwards, Raymond U Osarogiagbon> ;Translational Cancer Research. 2022 Dec 1
The TNM System Is Adequate for Making Treatment Decisions and Prognostication in Lung Cancer.
Ramón Rami-Porta, Raymond U Osarogiagbon, Hisao Asamura> ;Journal of Thoracic Oncology. 2022 Nov 1
Join now to see all

Lectures

Prospective comparative effectiveness trial of multidisciplinary lung cancer (LC) care.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Researchers: Lung Nodule Programs Can Catch Cancer EarlyMarch 10th, 2023
Baptist Cancer Center Research Proves Incidental Lung Nodule Program Effective in Detecting Cancer EarlyMarch 7th, 2023
RadNet, Google Health Collaborate to Develop AI-Based Lung Nodule Malignancy DiagnosticNovember 28th, 2022
Join now to see all

Hospital Affiliations

Baptist Memorial Hospital - MemphisMemphis, Tennessee
Baptist Memorial Hospital-DesotoSouthaven, Mississippi
Baptist Memorial Hospital-Golden TriangleColumbus, Mississippi
Baptist Memorial Hospital for WomenMemphis, Tennessee
Baptist Memorial Hospital-TiptonCovington, Tennessee
Methodist Le Bonheur Germantown HospitalGermantown, Tennessee
Saint Francis HospitalMemphis, Tennessee
Saint Francis Hospital-BartlettMemphis, Tennessee
Methodist Healthcare Memphis HospitalsMemphis, Tennessee

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Tennessee Network 5
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Carelink Health Plans PPO
First Health PPO
Great West PPO
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
Humana/ChoiceCare+ Network PPO
Multiplan PHCS PPO
Multiplan PPO
Qualchoice PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment